Neurochem Int:耳蜗连接蛋白26产后表达的减少能够诱导听力损失和影响柱细胞的发育

2019-05-08 AlexYang MedSci原创

GJB2基因(编码耳蜗连接蛋白26(Cx26))中的变异是非综合征耳聋最常见的病因。之前的研究表明了Gjb2基因在耳蜗上皮中的敲除能够引起严重的耳聋,显著的听毛细胞(HC)丧失和支持细胞缺失(一类支持细胞,PCs)。最近,有研究人员建立了Cx26表达呈现梯度减少的不同小鼠模型来调查耳蜗Cx26表达不同水平的减少对听力和PCs发育的影响。根据耳蜗Cx26减少的水平不同,这些模型被命名为高KD组、中K

GJB2基因(编码耳蜗连接蛋白26(Cx26))中的变异是非综合征耳聋最常见的病因。之前的研究表明了Gjb2基因在耳蜗上皮中的敲除能够引起严重的耳聋,显著的听毛细胞(HC)丧失和支持细胞缺失(一类支持细胞,PCs)。

最近,有研究人员建立了Cx26表达呈现梯度减少的不同小鼠模型来调查耳蜗Cx26表达不同水平的减少对听力和PCs发育的影响。根据耳蜗Cx26减少的水平不同,这些模型被命名为高KD组、中KD组和低KD组。在低KD组中,小鼠表现出了正常的听力且PCs发育良好。在高KD组,多达90%的支持细胞(SCs)不表达Cs26。这些小鼠表现出了重度耳聋、快速的听毛细胞退化和PCs发育不良。在中KD组中,将近一半的SCs不表达Cx26。然而,这些小鼠表现出了中度的耳聋和晚发的听毛细胞丧失。更多的是,中KD组中几乎所有的PCs均处于部分分化状态。

最后,研究人员指出,他们的结果表明了耳蜗Cx26产后表达的减少能够以剂量依赖的方式诱发听力损失。在一些SCs中,Cx26能够影响PCs的发育状态和听毛细胞的退化模式。PCs异常的发育模式也许是Gjb2相关听力损失的潜在原因。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2076127, encodeId=160120e6127c1, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri Jan 17 04:20:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976996, encodeId=1ae219e6996a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Oct 01 17:20:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306369, encodeId=40441306369f2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347396, encodeId=c00b134e3969b, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2076127, encodeId=160120e6127c1, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri Jan 17 04:20:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976996, encodeId=1ae219e6996a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Oct 01 17:20:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306369, encodeId=40441306369f2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347396, encodeId=c00b134e3969b, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=)]
    2019-10-01 linlin2312
  3. [GetPortalCommentsPageByObjectIdResponse(id=2076127, encodeId=160120e6127c1, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri Jan 17 04:20:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976996, encodeId=1ae219e6996a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Oct 01 17:20:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306369, encodeId=40441306369f2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347396, encodeId=c00b134e3969b, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=)]
    2019-05-10 ysjykql
  4. [GetPortalCommentsPageByObjectIdResponse(id=2076127, encodeId=160120e6127c1, content=<a href='/topic/show?id=abf6945365f' target=_blank style='color:#2F92EE;'>#连接蛋白#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94536, encryptionId=abf6945365f, topicName=连接蛋白)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Fri Jan 17 04:20:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1976996, encodeId=1ae219e6996a9, content=<a href='/topic/show?id=b9f11560065' target=_blank style='color:#2F92EE;'>#ROC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15600, encryptionId=b9f11560065, topicName=ROC)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d590125, createdName=linlin2312, createdTime=Tue Oct 01 17:20:00 CST 2019, time=2019-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1306369, encodeId=40441306369f2, content=<a href='/topic/show?id=aeb639230b7' target=_blank style='color:#2F92EE;'>#听力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39230, encryptionId=aeb639230b7, topicName=听力)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=96d4340, createdName=ysjykql, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1347396, encodeId=c00b134e3969b, content=<a href='/topic/show?id=88713e938c1' target=_blank style='color:#2F92EE;'>#发育#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37938, encryptionId=88713e938c1, topicName=发育)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=智者为医08, createdTime=Fri May 10 04:20:00 CST 2019, time=2019-05-10, status=1, ipAttribution=)]

相关资讯

Ear Nose Throat J:单边和双边听力损失风险因素分析

最近,有研究人员对2010年到2014年弗吉尼亚常规新生儿听力筛选(UNHS)中确定为听力损失的儿童进行了回顾性的研究,目的是比较患有单边听力损失(UHL)儿童和双边听力损失儿童(BHL)中联合委员会关于婴儿听力风险因素(JCIH)的发生率情况。研究包括了1004名听力损失儿童(占所有新生儿比例为0.2%),其中544名(51%)儿童至少具有1中JCIH风险因子。总的来讲,18%具有听力损失的儿童

盘点:听力损失与治疗新近进展

【1】Otol Neurotol:儿童突发感官听力损失研究 https://www.ncbi.nlm.nih.gov/pubmed/30870353最近,有研究人员调查了突发感官听力损失(SSNHL)儿童的临床特性、病因学、治疗结果和预后因素,目的是最终来指导儿科群体中SSNHL的临床诊断和治疗。研究包括了诊断为SSNHL的患者,时间为2011年11月到2017年12月。研究包括了25名SSN

Otol Neurotol:中频感官听力损失进展特性分析

最近,有研究人员鉴定和分析了中频感官听力损失(MFSNHL)随着时间的进展情况。研究包括了37名患者,并在一个三级护理听力学及神经科中心对2012年到2017年的图表进行了回顾分析。研究发现,平均的起始年龄为11.8岁(范围8个月到70岁)。在所有的个体中,平均的中频阈值为47dB,zai 500Hz和8kHz时为27dB。23名患者(62%)在均值为4年的跟踪调查内具有多重的听力图。起始听力图的

PLoS One:一种改善的快速遗传性听力损失基因变异鉴定方法

听力损失(HL)是一种常见的感官障碍。多半的HL案例可以归结到遗传起因。目前来讲,遗传性HL还没有有效的治疗方法,早期诊断来减少遗传性HL的发生率对遗传性HL的临床干预非常重要。之前的研究已经鉴定了111个非综合征听力损失基因。其中NSHL患者中最常见的变异基因在中国包括GJB2, SLC26A4和线粒体基因MT-RNR1。因此,在中国人口中开发HL基因芯片从而对SHL和NSHL患者进行定性的诊断

盘点:听力损失新近进展

听力损失(hearing loss)又称聋度(deafness)或听力级(hearing level)。是人耳在某一频率的听阈比正常听阈高出的分贝数。由于年龄关系产生的听力损失称为老年性耳聋;由于社会环境噪声(年龄、职业性噪声和疾病等影响除外)产生的听力损失称为社会性耳聋;职业性噪声导致的听力损失称为噪声性耳聋。梅斯医学小编整理了近期听力损失的研究进展,与大家一起分享学习!【1】Otol Ne

Clin Exp Otorhinolaryngol:糖皮质激素受体α和组蛋白脱乙酰化酶2对肾上腺糖皮质激素的响应能够预测突发感官听力损失的预后

最近,有研究人员在重度到永久性突发感官听力损失(SSNHL)患者中调查了外周血单核细胞(PBMCs)中的糖皮质激素受体(GR)和组蛋白脱乙酰化酶2(HDAC2)基因表达的情况,并探索了GRs和HDAC2在糖皮质激素(GC)不敏感中的作用。研究包括了55名重度到永久性SSNHL患者。根据GC治疗后的听力改善结果,患者分配成2个小组:GC敏感组和GC抗性组。参照组包括了20名健康的志愿者且不具有听力损